First Personal Financial Services Ligand Pharmaceuticals Inc Transaction History

First Personal Financial Services

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 07, 2018	SELL	$150.77 - $207.98 $14,021 - $19,342	-93 Closed	0 $0
Q1 2018 May 10, 2018	BUY	$138.63 - $182.62 $12,892 - $16,983	93 New	93 $15,000
Q4 2017 Jan 25, 2018	SELL	$128.36 - $147.04 $7,444 - $8,528	-58 Closed	0 $0
Q3 2017 Nov 01, 2017	BUY	$120.91 - $137.94 $7,012 - $8,000	58	58 $8,000

256

18.1M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.91B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of First Personal Financial Services, based on Form 13F filings with the SEC.

Stay updated on First Personal Financial Services with notifications on news.